Distressing Life Events, Attentional Vigilance and Flexibility, and Sublime Feeling during Impactful Dreams
Medical Research Archives · 30.09.2026 · 14 (9)
DOI: 10.18103/mra.2026.0649 ↗Kurz gefasst
Fachartikel in der Zeitschrift Medical Research Archives, online erschienen am 30.09.2026. Verfasst von Donald Kuiken. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
An interdisciplinary review of research on impactful dreams reconsiders the tripartite division between nightmares, existential dreams, and transcendent dreams. This review facilitates articulation of two hierarchies of aesthetic-epistemic modes of oneiric metacognition: (a) a hierarchy of metaphoric relations and (b) a hierarchy of narrative relations. Apex modes of metaphoric relations are involved in the extended, unfolding, and "living" interplay of categories that constitute sublime disquietude (in existential dreams), and apex modes of narrative relations are involved in the extended, unfolding, and "living" interplay of temporal perspectives that constitute sublime enthrallment (in transcendent dreams). Recent evidence clarifies how the processes that provide cardiac vagal regulation of the autonomic nervous system (ANS) differentiate the vigilant re-experiencing of nightmares from the flexible reminiscences of existential and transcendent dreams.
Zitieren
APA
Kuiken, D. (2026). Distressing Life Events, Attentional Vigilance and Flexibility, and Sublime Feeling during Impactful Dreams. Medical Research Archives, 14(9). https://doi.org/10.18103/mra.2026.0649
Vancouver
Kuiken D. Distressing Life Events, Attentional Vigilance and Flexibility, and Sublime Feeling during Impactful Dreams. Medical Research Archives. 2026;14(9). doi:10.18103/mra.2026.0649
BibTeX
@article{Kuiken2026,
author = {Kuiken, Donald},
title = {Distressing Life Events, Attentional Vigilance and Flexibility, and Sublime Feeling during Impactful Dreams},
journal = {Medical Research Archives},
year = {2026},
volume = {14},
number = {9},
doi = {10.18103/mra.2026.0649}
}
EUVIMED